Despite COVID-19, we are operating at full capacity and all project work is operating as usual.

Clinically predictive preclinical efficacy testing services at your disposal


Pharmatest has provided assistance for almost a hundred pharmaceutical, biotechnology and nutraceutical companies worldwide in their efficacy research. Most of our customers come to us before their candidates enter official pipelines and therefore wish to remain undisclosed. Therefore, we do not disclose any of our customers unless they specifically agree.

Below you can find some testimonials of our customers who have been satisfied with the quality of our services.


“It was a great pleasure working with Pharmatest.  The scientific expertise and advice offered by the Pharmatest team were top notch.  There was excellent, proactive communication from the very beginning of the project, which finished on time and within budget. I have no hesitations in recommending Pharmatest as a high-quality CRO for preclinical services in skeletal diseases.” - Dr. Hubert Chen, Chief Medical Officer, Pfenex Inc., USA

"Bayer has worked for several years with Pharmatest and we are very impressed about the high quality of the work they have done for us." - Dr. Karl Ziegelbauer, SVP Therapeutic Research Groups, Pharmaceuticals Division, Bayer Pharma AG, Germany

"Exelixis has been working with Pharmatest since 2011, and we have been very pleased with their excellent data quality, detailed and thorough reports, and highly professional and knowledgeable staff.” - Dr. Dana T. Aftab, Executive Vice President, Business Operations, Exelixis Inc., USA

 "Pharmatest has been our preferred supplier of preclinical proof-of-concept studies for some time now and we are very satisfied about the high quality and scientific expertise that they provide." - Dr. Satu Vainikka, CEO, Valirx Plc, UK

 "Virobay has worked with Pharmatest on both in vitro and in vivo model analysis of drug candidates and we are very pleased with the excellent quality of their work and the high level of scientific expertise they provide to our studies.” - Dr. Leslie Holsinger, Vice President of Biology, Virobay Inc., USA

 "It has been a pleasure working with the Pharmatest team. You have been an excellent communicator, always informing us promptly on changes or questions that have come up and providing great feedback to our questions. We certainly experience Pharmatest as a very competent company with very professional employees." - Hanne Heidenheim Bak, M.Sc. Pharm, Senior Project Director, Head of Project Management, Zealand Pharma A/S, Denmark

“Orion started to use services of Pharmatest more than 10 years ago, and we are happy about the excellent scientific quality of their work and reporting.” – Dr. Pekka Kallio, Head of Oncology Research, Orion Oyj, Finland

"Amura has worked closely with Pharmatest for over a decade in the areas of bone turnover and bone metastases.  Pharmatest has provided support and advice in addition to a first class in vitro and in vivo screening service for the analysis and progression of Amura's drug candidates. We are always impressed with the excellent quality of their work and the high level of scientific expertise they provide to our studies.” - Dr. Nick Flinn, Head of Pre-clinical Development, Amura Therapeutics, England

”Transgene and Pharmatest have successfully collaborated since 2009 for the in vitro and in vivo preclinical evaluation of TG’s monoclonal platform in different skeletal diseases. Transgene was particularly impressed by the high professionalism of Pharmatest’s scientist staff, who participated actively nearby our teams in the designs, execution and analysis of the experiments.” – Dr. Jean-Baptiste Marchand, Head of Proteins Science Group, Transgene, France